Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

about

Opportunities and challenges for successful use of bevacizumab in pediatrics.Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases Safety of bevacizumab in patients younger than 4 years of age.

P2860

Q30454883-8452F859-AC3F-40ED-9BAB-88C247C07A14 Q34680171-4EC25360-53B9-45CC-8731-6DB5ABA6C58B Q38575870-91E51382-9FC8-48A0-8E11-8021846D1FE6

P2860

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

Item

http://www.wikidata.org/entity/Q48632325

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

@en

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

@nl

type

Item

label

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

@en

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

@nl

prefLabel

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

@en

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

@nl

P1476

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma

@en

P2093

Asteria Albert

http://www.w3.org/2001/XMLSchema#string

Jaume Mora

http://www.w3.org/2001/XMLSchema#string

Nuria Conde

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors.

Lingual alveolar soft part sarcoma in a child managed successfully with surgery and chemotherapy.

Antiangiogenic activities of 2,5-dimethyl-celecoxib on the tumor vasculature.

Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma.

Primary alveolar soft-part sarcoma of the mediastinum: a clinicopathological and immunohistochemical study of two cases.

P304

1071-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.23241

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ofelia Cruz

P577

2011-07-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21744483

http://www.w3.org/2001/XMLSchema#string

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

about

P2860

P2860

Antiangiogenic treatment as a pre-operative management of alveolar soft-part sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698